| 摘要 |
<p>The invention refers to a pharmaceutical composition useful in treating alcohol dependence or abuse, which comprises at least one compound selected from the group of partial agonists of 5-TH1A receptors and at least one selective inhibitor compound of B-type monoamino-oxidase (MAO). The invention also relates to a method for treating alcohol dependence or abuse or genetic complications caused by alcoholism, which comprises the administration, to a patient suffering from these disorders, of a pharmaceutical composition comprising at least one partial agonist compound of 5-TH1A receptors and at least one selective inhibitor compound of B-type monoamino-oxidase (MAO).</p> |
